Research Article
A Validated RP-HPLC Stability Method for the Estimation of Chlorthalidone and Its Process-Related Impurities in an API and Tablet Formulation
| Impurities | 40°C/75%RH | 25°C/60%RH | Limit | Initial | 1 M | 2 M | 3 M | 6 M | 3 M | 6 M |
| For API | Impurity B (%w/w) | ND | ND | ND | ND | ND | 0.01 | 0.01 | NMT 0.10% | Stage II (%w/w) | ND | ND | ND | 0.0 | 0.0 | ND | ND | NMT 0.15% | Stage III (%w/w) | ND | ND | 0.01 | 0.01 | 0.01 | ND | ND | NMT 0.15% | Single large unknown impurity (%w/w) | 0.07 | 0.05 | 0.03 | 0.05 | 0.06 | 0.05 | 0.04 | NMT 0.10% | Total impurities (%w/w) | 0.29 | 0.20 | 0.21 | 0.26 | 0.27 | 0.17 | 0.15 | NMT 0.5% | For formulation | Impurity B (%w/w) | ND | ND | ND | ND | ND | 0.01 | 0.01 | NMT 0.10% | Stage II (%w/w) | ND | ND | ND | 0.0 | 0.0 | ND | ND | NMT 0.15% | Stage III (%w/w) | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | ND | ND | NMT 0.15% | Single large unknown impurity (%w/w) | 0.05 | 0.05 | 0.07 | 0.06 | 0.09 | 0.06 | 0.05 | NMT 0.10% | Total impurities (%w/w) | 0.30 | 0.28 | 0.27 | 0.26 | 0.25 | 0.27 | 0.25 | NMT 0.5% |
|
|
ND: not detected.
|